Vimarsana
Biggest News Aggregation in the World

Alekshmy Srinivas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alekshmy Srinivas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alekshmy Srinivas Today - Breaking & Trending Today

Genetic study predicts optimal use of 'Tacrolimus' for kidney transplant patients - Vimarsana News

Genetic study predicts optimal use of 'Tacrolimus' for kidney transplant patients

The dose prediction study was focused on the immunosuppressant drug tacrolimus, which is given to a kidney, heart or liver transplant patient to lower the body's immunity and thereby considerably reducing the chances of organ rejection.

Source: ummid.com
Study predicts optimal use of immunosuppressant drug for kidney transplant patients - Vimarsana News

Study predicts optimal use of immunosuppressant drug for kidney transplant patients

In a path-breaking genetic study that could significantly reduce the risk of organ rejection and other medical complications, scientists of the Rajiv Gandhi Centre for Biotechnology (RGCB) here have formulated a method to predict the optimal ...

Study Predicts Optimal Use Of Immunosuppressant Drug For Kidney Transplant Patients - Vimarsana News

Study Predicts Optimal Use Of Immunosuppressant Drug For Kidney Transplant Patients

Thiruvananthapuram, Dec 6 (IANS) In a path-breaking genetic study that could significantly reduce the risk of organ rejection and other medical complications,

Study predicts optimal use of immunosuppressant drug for kidney transplant patients - Vimarsana News

Study predicts optimal use of immunosuppressant drug for kidney transplant patients

In a path-breaking genetic study that could significantly reduce the risk of organ rejection and other medical complications, scientists of the Rajiv Gandhi Centre for Biotechnology (RGCB) here have formulated a method to predict the optimal dose of an immunosuppressant drug given to kidney transplant patients.